Dan Janney

Daniel Janney is the Managing Director at Alta Partners. Dan joined Alta immediately following the firm’s founding in 1996, and was a co-founder of the Alta BioPharma effort.

Dan focuses on investments in biopharmaceutical products and therapeutics. Dan has been directly involved in the funding and development of over 25 life sciences companies. Dan is currently on the board of directors of a number of companies, including Alba Therapeutics, Esperion Therapeutics, Neothetics, Prolacta Bioscience and ViroBay.

In addition, Dan led Alta’s investments in ChemGenex Pharmaceuticals, CoTherix, Definity Health, DiscoveRx, Dynavax, Endonetics, Ilex Oncology, InterMune, LJL Biosystems and Mako Surgical.

Prior to joining Alta, Dan was a senior investment banker at Montgomery Securities, focusing on life sciences companies. Dan is also a member of The President's Council of the Gladstone Institutes.

Dan holds a Bachelor of Arts in History from Georgetown University and a Master of Business Administration from the Anderson School at the University of California, Los Angeles.

Dan Janney is the Managing Director at Alta Partners, based in United States, North America. With a background in Financial Services, Dan Janney has a rich history of leadership and innovation. Dan Janney studied B.A. History @ Georgetown University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.